Close

China’s Luye Medical to buy Australian Private-Hospital Operator, Healthe Care Australia Pty. Ltd

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...

PatientPoint improves health outcomes with new MyHealthTeam partnership

PatientPoint, one of the country’s leading digital health companies...
Healthe Care Australia Pty. Ltd., one of the country’s largest private-hospital operators, will be bought from private equity owner Archer Capital by China’s Luye Medical Group Co. for 938 million Australian dollars (US$688 million).

The health-care company said in a statement Sunday a sale had been agreed with Luye Medical, a division of Luye Group which also has a significant stake in Hong Kong-listed Luye Pharma Group Ltd.

Acquired by Archer in mid-2011, Sydney-based Healthe Care operates 17 hospitals with more than 1,800 beds located in major cities and key regional areas across Australia. Under Archer, the company has teadily expanded with a series of acquisitions, including Townsville Private in 2014 and Robina Private earlier this year.

“There are very few private hospital portfolio acquisition opportunities anywhere in the world and to be able to enter the Australian market with an acquisition of scale such as Healthe Care represents a reat opportunity,” Luye Group Chairman Liu Dian Bo said.

He said the deal would provide the Chinese company with a platform to build a health-care services company in Australia, China and other parts of Asia.

Archer was advised on the deal by Luminis Partners and Morgan Stanley, while Luye Medical was advised by Barclays, the companies said in the statement. The acquisition is expected to be completed in the first quarter of 2016.

Latest stories

Related stories

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...

PatientPoint improves health outcomes with new MyHealthTeam partnership

PatientPoint, one of the country’s leading digital health companies...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back